SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-21-078265
Filing Date
2021-06-08
Accepted
2021-06-08 16:32:00
Documents
3
Group Members
ALLEN GABRIELANTHONY CARACCIOLOANTONIO PARISIARLYN J. BOSSENBROOKARTHUR L. WILMESBRENDAN THORSONCHARLES M. JOHNSON JRDR. RICHARD PESTELLFRANCESCO TOSCOFREDERICK J. AXELBERDGLENN EISENBERGJACK CHITAYATJEFFREY D. WEINERJEFFREY PAUL BEATYJOE RECTORJONATHAN H

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2119016d1_sc13da.htm SC 13D/A 407801
2 EXHIBIT 99.9 tm2119016d1_ex99-9.htm EX-99.9 26978
3 EXHIBIT 99.10 tm2119016d1_ex99-10.htm EX-99.10 6910
  Complete submission text file 0001104659-21-078265.txt   443900
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Subject) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: SC 13D/A | Act: 34 | File No.: 005-79349 | Film No.: 211002508
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2945 NW LURAY TERRACE PORTLAND OR 97210
Business Address
Rosenbaum Paul (Filed by) CIK: 0001863643 (see all company filings)

Type: SC 13D/A